Skip to main content

Table 4 Combinatorial effects of miRNA polymorphisms and environmental factors on rectal cancer risk

From: Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility

Characteristics

miR-130bTT

miR-130bTC + CC

miR-200bTT

miR-200bTC + CC

miR-495AA + AC

miR-495CC

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

Age

  < 63 years

1.000 (reference)

1.222 (0.706–2.115)

1.000 (reference)

1.032 (0.599–1.780)

1.000 (reference)

1.563 (0.874–2.793)

  ≥ 63 years

1.097 (0.672–1.790)

0.696 (0.412–1.176)

0.826 (0.475–1.436)

0.854 (0.515–1.415)

1.107 (0.706–1.736)

1.784 (1.038–3.064)

Gender

 Male

1.000 (reference)

0.799 (0.469–1.362)

1.000 (reference)

1.214 (0.707–2.085)

1.000 (reference)

1.772 (0.975–3.221)

 Female

1.087 (0.664–1.782)

0.966 (0.570–1.636)

1.454 (0.835–2.531)

1.303 (0.753–2.255)

0.885 (0.565–1.387)

1.273 (0.730–2.222)

Hypertension

 No

1.000 (reference)

0.924 (0.531–1.610)

1.000 (reference)

0.799 (0.457–1.399)

1.000 (reference)

1.906 (1.050–3.461)

 Yes

2.539 (1.535–4.200)

1.854 (1.076–3.196)

1.921 (1.101–3.350)

2.171 (1.279–3.683)

2.362 (1.496–3.727)

3.404 (1.902–6.092)

Diabetes mellitus

 No

1.000 (reference)

0.832 (0.544–1.274)

1.000 (reference)

0.872 (0.571–1.332)

1.000 (reference)

1.686 (1.077–2.642)

 Yes

2.535 (1.382–4.651)

2.545 (1.385–4.676)

1.946 (0.998–3.793)

3.261 (1.798–5.913)

3.088 (1.851–5.152)

3.758 (1.685–8.383)

Homocysteine (μmol/L)

  < 13.3

1.000 (reference)

0.795 (0.531–1.191)

1.000 (reference)

1.191 (0.794–1.787)

1.000 (reference)

1.641 (1.069–2.518)

  ≥ 13.3

0.936 (0.451–1.943)

1.199 (0.579–2.484)

1.938 (0.904–4.152)

0.820 (0.394–1.708)

1.211 (0.653–2.248)

1.619 (0.612–4.282)

Folate (nmol/L)

  > 3.7

1.000 (reference)

0.853 (0.571–1.272)

1.000 (reference)

0.977 (0.654–1.458)

1.000 (reference)

1.478 (0.956–2.286)

  ≤ 3.7

2.427 (1.152–5.114)

2.193 (0.948–5.076)

1.645 (0.685–3.953)

2.512 (1.228–5.138)

2.069 (1.016–4.216)

3.829 (1.577–9.300)

Triglyceride (mg/dL)

  < 150

1.000 (reference)

0.843 (0.545–1.303)

1.000 (reference)

0.902 (0.584–1.394)

1.000 (reference)

0.934 (0.567–1.538)

  ≥ 150

0.524 (0.300–0.914)

0.426 (0.227–0.799)

0.373 (0.187–0.745)

0.609 (0.352–1.055)

0.457 (0.196–1.066)

0.359 (0.179–0.718)

HDL-C (mg/dL)

  ≥ 40

1.000 (reference)

0.839 (0.542–1.299)

1.000 (reference)

0.965 (0.624–1.492)

1.000 (reference)

1.119 (0.683–1.836)

  < 40

2.706 (1.500–4.882)

2.259 (1.162–4.394)

2.575 (1.312–5.053)

2.624 (1.442–4.775)

4.639 (1.799–11.961)

2.137 (1.141–4.001)

  1. Upper and lower 15% cut-off values of homocysteine and folate were 13.3 μmol/L and 3.7 ng/mL, respectively
  2. AOR, adjusted odds ratio (adjusted for age, gender, hypertension, diabetes mellitus); CI, confidence interval